Síndrome de Marfán

Marfan Syndrome is an autosomic dominant genetic disorder of the elastic fibers of connective tissue. Although neonatal and infant forms of the disease exist, the classic Marfan Syndrome is the most frequent form of presentation in childhood and adolescence, whith a hereditary background in 70 to 85...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oliva N,Pamela, Moreno A,Regina, Toledo G,M. Isabel, Montecinos O,Andrea, Molina P,Juan
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2006
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006001100014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872006001100014
record_format dspace
spelling oai:scielo:S0034-988720060011000142014-01-24Síndrome de MarfánOliva N,PamelaMoreno A,ReginaToledo G,M. IsabelMontecinos O,AndreaMolina P,Juan Genetic diseases, inborn heart defects, congenital Marfan syndrome Marfan Syndrome is an autosomic dominant genetic disorder of the elastic fibers of connective tissue. Although neonatal and infant forms of the disease exist, the classic Marfan Syndrome is the most frequent form of presentation in childhood and adolescence, whith a hereditary background in 70 to 85% of cases. Due to the natural evolution of the disease, there is a progressive involvement of different organs or systems such as skeletal, cardiovascular, dura, ocular, skin-integument and lungs. However, the suspicion must arise on skeletal clinical aspects which are first evident signs. The cardiovascular involvement appears later but is the major life threatening complication. When suspecting Marfan phenotype, it is mandatory to apply Ghent criteria based on family history and clinical findings to establish the diagnosis. If diagnosis is confirmed, the severity of organ involvement must be assessed, to take preventive and/or therapeutic measures, including the search of new cases among relatives. When patients do not fulfill the diagnostic criteria, they must have a yearly evaluation considering the natural progressive evolution of the disease. The aim of this review is to spread and unify criteria on this disease whose diagnosis is eminently clinical, that requires early integral and updated management by a multidisciplinary group, to obtain the best quality of life and survivalinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.11 20062006-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006001100014es10.4067/S0034-98872006001100014
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Genetic diseases, inborn
heart defects, congenital
Marfan syndrome
spellingShingle Genetic diseases, inborn
heart defects, congenital
Marfan syndrome
Oliva N,Pamela
Moreno A,Regina
Toledo G,M. Isabel
Montecinos O,Andrea
Molina P,Juan
Síndrome de Marfán
description Marfan Syndrome is an autosomic dominant genetic disorder of the elastic fibers of connective tissue. Although neonatal and infant forms of the disease exist, the classic Marfan Syndrome is the most frequent form of presentation in childhood and adolescence, whith a hereditary background in 70 to 85% of cases. Due to the natural evolution of the disease, there is a progressive involvement of different organs or systems such as skeletal, cardiovascular, dura, ocular, skin-integument and lungs. However, the suspicion must arise on skeletal clinical aspects which are first evident signs. The cardiovascular involvement appears later but is the major life threatening complication. When suspecting Marfan phenotype, it is mandatory to apply Ghent criteria based on family history and clinical findings to establish the diagnosis. If diagnosis is confirmed, the severity of organ involvement must be assessed, to take preventive and/or therapeutic measures, including the search of new cases among relatives. When patients do not fulfill the diagnostic criteria, they must have a yearly evaluation considering the natural progressive evolution of the disease. The aim of this review is to spread and unify criteria on this disease whose diagnosis is eminently clinical, that requires early integral and updated management by a multidisciplinary group, to obtain the best quality of life and survival
author Oliva N,Pamela
Moreno A,Regina
Toledo G,M. Isabel
Montecinos O,Andrea
Molina P,Juan
author_facet Oliva N,Pamela
Moreno A,Regina
Toledo G,M. Isabel
Montecinos O,Andrea
Molina P,Juan
author_sort Oliva N,Pamela
title Síndrome de Marfán
title_short Síndrome de Marfán
title_full Síndrome de Marfán
title_fullStr Síndrome de Marfán
title_full_unstemmed Síndrome de Marfán
title_sort síndrome de marfán
publisher Sociedad Médica de Santiago
publishDate 2006
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006001100014
work_keys_str_mv AT olivanpamela sindromedemarfan
AT morenoaregina sindromedemarfan
AT toledogmisabel sindromedemarfan
AT montecinosoandrea sindromedemarfan
AT molinapjuan sindromedemarfan
_version_ 1718436294287163392